Comparing the efficacy of different surfactant on critical neonatal respiratory distress syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPN-17011344

Enrollment

Unknown

Registered

2017-05-09

Start date

2017-05-22

Completion date

Unknown

Last updated

2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal respiratory distress syndrome

Interventions

calsurf group and curosurf group:surfactant therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. infants <34 weeks gestation; 2. the diagnosis of neonatal respiratory distress syndrome is confirmed,and III or IV level on chest X-ray.

Exclusion criteria

Exclusion criteria: Exclusion criteria are repeated convulsions, coma or intracranial hemorrhage; or Combined with other severe life-threatening diseases, or severe poisoning symptoms and gastrointestinal bleeding

Design outcomes

Primary

Measure	Time frame
blood gas analysis;BPD;complication;	—

Countries

China

Contacts

Public ContactChang Liwen

Tongji hospital of Huazhong University of Science and Technology

lwchang@tjh.tjmu.edu.cn+86 13971619293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026